Alyeska Investment Group’s IN8bio INAB Stock Holding History

Alyeska Investment Group’s Portfolio INAB Stock Details INAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.4M	Sell	944,319 -13,165	-1%	-$25.5K	﹤0.01%	561
2025 Q4	$2.23M	Buy	957,484 +875,000	+1,061%	+$1.66M	0.01%	519
2025 Q3	$179K	Hold	82,484	–	–	﹤0.01%	576
2025 Q2	$172K	Buy	82,484 +13,165	+19%	+$53.5K	﹤0.01%	539
2025 Q1	$345K	Sell	69,319 -99,457	-59%	-$793K	﹤0.01%	476
2024 Q4	$1.3M	Buy	168,776 +154,282	+1,064%	+$1.35M	﹤0.01%	485
2024 Q3	$117K	Sell	14,494 -6,873	-32%	-$124K	﹤0.01%	506
2024 Q2	$764K	Buy	21,367 +6,500	+44%	+$209K	﹤0.01%	482
2024 Q1	$526K	Sell	14,867 -12,455	-46%	-$470K	﹤0.01%	430
2023 Q4	$1.12M	Buy	+27,322	New	+$873K	0.01%	405

Other funds holding INAB

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

BCM

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

TCBWMS

Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return

Alyeska Investment Group's INAB Position: Q1 2026 in Review

Alyeska Investment Group reduced its IN8bio (INAB) stake by 1.4% in Q1 2026, selling an estimated $25.5K and leaving 944,319 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #561.

Alyeska Investment Group first reported a position in INAB in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.23M in Q4 2025. 19 funds tracked by Wall St. Rank hold INAB as of Q1 2026.

Alyeska Investment Group held 944,319 shares of IN8bio worth $1.4M as of Q1 2026.
Alyeska Investment Group sold 13,165 IN8bio shares in Q1 2026, an estimated $25.5K.
IN8bio made up ﹤0.01% of Alyeska Investment Group's portfolio in Q1 2026, its #561 holding.
Alyeska Investment Group first reported a position in IN8bio in Q4 2023 and has held it in 10 quarters since.
Alyeska Investment Group's IN8bio position peaked at $2.23M in Q4 2025.
19 funds tracked by Wall St. Rank held IN8bio as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.